Chemopreventive role of etoricoxib (MK-0663) in experimental colon cancer: Induction of mitochondrial proapoptotic factors

European Journal of Cancer Prevention

Volumn 19, Issue 4, 2010, Pages 280-287

  Tanwar, Lalita ^a   Vaish, Vivek ^a   Sanyal, Sankar Nath ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

M; Apoptosis; Bax; Bcl 2; Colon cancer; Cytochrome C; Etoricoxib

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CYTOCHROME C; EDETIC ACID; ETORICOXIB; PROTEIN BAX; PROTEIN BCL 2; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; COLONIC NEOPLASMS; CYTOCHROMES C; GENES, BCL-2; INTESTINAL MUCOSA; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 77955669840     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283396470     Document Type: Article

References (30)

1. Baran JA, Sandler RS (2000). Nonsteroidal anti-inflammatory drugs and cancer prevention. Ann Rev Med 51:511-523.
2. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the priniciple of protein-dye binding. Anal Biochem 72:248-254.
3. Cao JW, Luo HS (1997). Bcl 2 gene family and gastrointestinal tumors. Xin Xiaohuabingxue Zazhi 5:734-735.
4. Corpet DE, Tache S (2002). Most effective colon cancer chemopreventive agents in rats: a review of aberrant crypt foci and tumour data, ranked by potency. Nutr Cancer 43:1-21.
5. Green DR, Reed JC (1998). Mitochondria and apoptosis. Science 281:1309-1312.
6. Gwyn K, Sinicrope FA (2002). Chemoprevention of colorectal cancer. Am J Gastroenterol 97:13-21.
7. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, et al. (1996). Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52:237-245.
8. Heerdt BG, Houston MA, Mariadason JM, Augenlicht LH (2000). Dissociation of staurosporine induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cell: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (DCM). Cancer Res 60:6704-6713.
9. Kanwar SS, Vaiphei K, Nehru B, Sanyal SN (2008). Antioxidative effects of nonsteroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rats. J Environ Pathol Toxicol Oncol 27:89-100.
10. Kaur J, Sanyal SN (2010). Modulation of inflammatory changes in early stages of colon cancer through activation of PPARg by diclofenac. Eur J Cancer Prev (in press).
11. Keller JJ, Giardiello FM (2003). Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol Ther 2:140-149.
12. Krajewska M, Kitada S, Winter JN, Variakojis D, Lichtenstein A, Zhai D, et al. (2008). Bcl-B expression in human epithelial and non-epithelial malignancies. Clin Cancer Res 14:3011-3021.
13. Liu HF, Liu WW, Fang DC, Men RP (1998). Expression of bcl-2 protein in gastric carcinoma and its significance. World J Gastroenterol 4:228-230.
14. Melen-Mucha G, Niewiadowska H (2002). Frequency of proliferation, apoptosis, and their ratio during rat colon carcinogenesis and their characteristic pattern in the dimethylhydrazine-induced colon adenoma and carcinoma. Cancer Invest 20:700-712.
15. Millan A, Huerta S (2009). Apoptosis-inducing factor and colon cancer. J Surg Res 151:163-170.
16. Mouille B, Robert V, Blachier F (2004). Adaptive increase of ornithine production and decrease of ammonia metabolism in rat colonocytes and hyperproteic diet ingestion. Am J Physiol 287:344-351.
17. Riendeau D, Percival MD, Brideau C, Charleson S, Dube D, Ethier D, et al. (2001). Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 296:558-566.
18. Roediger WEW, Truelove SC (1979). Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut 20:484-488.
19. Ruchko M, Gorodnya O, LeDoux SP, Alexeyev MF, Al-Mehdi AB, Gillespie MN (2005). Mitochondrial DNA damage triggers mitochondrial dysfunction and apoptosis in oxidant challenged lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 288:L530-L535.
20. Saini MK, Sharma P, Kaur J, Sanyal SN (2009). The cycloxygenase-2 inhibitor Etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model. J Environ Pathol, Toxicol Oncol 28:39-46.
21. Salvioli S, Aradizzoni A, Franceschi C, Cossarizza A (1997). JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77-82.
22. Sharma P, Kaur J, Sanyal SN (2010). Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor, on aberrant crypt formation and apoptosis in 1,2 dimethylhydrazine induced colon carcinogenesis in rat model. Nutr Hosp 25:39-48. [ahead of print]
23. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998). Modulation of apoptosis and BCl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362-366.
24. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B (1995). bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241.
25. Steinbach G, Lynch PM, Phillips RKS,Wallace MH, Hawk E, Gordon GB, et al. (2000). The effect of celecoxib, a cycloxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946-1952.
26. Tavolari S, Bonafe M, Marini M, Ferreri C, Bartolini G, Brighenti E, et al. (2008). Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Carcinogenesis 29:371-380.
27. Wakabayashi K (2000). NSAIDs as cancer preventive agents. Asian Pacific J Cancer Prev 1:97-113.
28. Wu GS, Zou SQ, Liu ZR, Tang ZH, Wang JH (2003). Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. World J Gastroenterol 9:1302-1306.
29. Yang XJ, Chen SB, Bao JZ, Wang Y, Zhang ZB, Zhang XK, Zhang XR (1997). Effect of HGF on etoposide induced apoptosis and bcl-2 gene expression for hepatocellular carcinoma. Xin Xiaohuabingxue Zazhi 5:518-519.
30. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000). Role of Bax in the apoptotic response to anticancer agents. Science 290:989-992.